Cheng Z.J. et al.
2019 Novel coronavirus : where we are and what we know
Infection, 2020; doi/org/101007/s15010-020-01401-y
Cassone A. et al.
Relationship between SARS-2-COV, ACE 2 and antihypertensives
Ahed of print
Moore J.B. et al
Cytokine release syndrome in severe COVID-19
Paules C.I. et al.
JAMA, January 2020; doi: 10.1001/jama.2020.0757
EMBO Rep., April 2020; doi: 10.15252/embr.202050334
Flaxman S. et al.
Li R. et al.
Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV-2).
Science, May 2020; doi: 10.1126/science.abb3221
Letter to the Editor
Aerosol and surface stability of SARS-CoV-2 as compared with SARS-CoV-1
NEJM, March 2020; doi: 10.1056/nejmc2004973
Lyon study group on Covid-19 infection
Wilder-Smith A. et al.
Lancet Infect Dis., May 2020; doi: 10.1016/S1473-3099(20)30129-8
Sjödin H. et al.
Euro Surveill., April 2020; doi: 10.2807/1560-7917.ES.2020.25.13.2000280
Salzberger B. et al.
Clerkin K.J. et al.
Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046941
Vardeny O. et al.
Circulation, March 2020; doi: 10.1161/CIRCULATIONAHA.120.046837
Zhao J et al.
Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019
Clinical Infectious Diseases, April 2020; doi:10.1093/cid/ciaa414
Xiang F. et al
Antibody detection and dynamic characteristics in patients with COVID-19
Clinical Infectious Diseases, April 2020; doi: 10.1093/cid/ciaa461
Henry B.M. et al.
Hematologic, biochemical and immune biomarker abnormalities associated
with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis.
Clin Chem Lab Med., April 2020; doi: 10.1515/cclm-2020-0369
Chen X. et al.
Bhimraj A. et al
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.
Disponibile online at https://www.idsociety.org/COVID19guidelines
Grein J et al.
N Engl J Med., April 2020; doi: 10.1056/NEJMoa2007016